Where do conventional OADs stand
The last two decades have witnessed unprecedented activity in the field of OADs with many new drugs becoming available. Concerns with OAD include cardiovascular safety, fear about hypoglycemia, weight gain etc. In this article we attempt to review OADs , sulfonylureas in particular, in the light of...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
| Series: | Indian Journal of Endocrinology and Metabolism |
| Subjects: | |
| Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=8;spage=252;epage=255;aulast=Sahay |
| _version_ | 1811205122834825216 |
|---|---|
| author | Rakesh Kumar Sahay V Sri Nagesh |
| author_facet | Rakesh Kumar Sahay V Sri Nagesh |
| author_sort | Rakesh Kumar Sahay |
| collection | DOAJ |
| description | The last two decades have witnessed unprecedented activity in the field of OADs with many new drugs becoming available. Concerns with OAD include cardiovascular safety, fear about hypoglycemia, weight gain etc. In this article we attempt to review OADs , sulfonylureas in particular, in the light of the newer agents. |
| first_indexed | 2024-04-12T03:25:11Z |
| format | Article |
| id | doaj.art-7c3e274d42664f22a2904ac27f380348 |
| institution | Directory Open Access Journal |
| issn | 2230-8210 2230-9500 |
| language | English |
| last_indexed | 2024-04-12T03:25:11Z |
| publishDate | 2012-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Endocrinology and Metabolism |
| spelling | doaj.art-7c3e274d42664f22a2904ac27f3803482022-12-22T03:49:44ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102230-95002012-01-0116825225510.4103/2230-8210.104053Where do conventional OADs standRakesh Kumar SahayV Sri NageshThe last two decades have witnessed unprecedented activity in the field of OADs with many new drugs becoming available. Concerns with OAD include cardiovascular safety, fear about hypoglycemia, weight gain etc. In this article we attempt to review OADs , sulfonylureas in particular, in the light of the newer agents.http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=8;spage=252;epage=255;aulast=SahayConventional OADssulfonylureasnew roles |
| spellingShingle | Rakesh Kumar Sahay V Sri Nagesh Where do conventional OADs stand Indian Journal of Endocrinology and Metabolism Conventional OADs sulfonylureas new roles |
| title | Where do conventional OADs stand |
| title_full | Where do conventional OADs stand |
| title_fullStr | Where do conventional OADs stand |
| title_full_unstemmed | Where do conventional OADs stand |
| title_short | Where do conventional OADs stand |
| title_sort | where do conventional oads stand |
| topic | Conventional OADs sulfonylureas new roles |
| url | http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=8;spage=252;epage=255;aulast=Sahay |
| work_keys_str_mv | AT rakeshkumarsahay wheredoconventionaloadsstand AT vsrinagesh wheredoconventionaloadsstand |